OLMA
Olema Pharmaceuticals, Inc. · Healthcare
Director Cyrus Harmon sold $257K of Olema Pharmaceuticals, Inc.
Sold$257,450
$10.30Price
25,000Shares
−3%Stake
What OLMA did after the filing
- The stock from Wed, Jun 5 open, $13.87
- +3.2%
- S&P 500, same days
- +3.8%
Measured over 30 trading days, to the Jul 19 close.
Traded Fri, May 31. Filed Tue, Jun 4, 5:00 PM ET, after the close. Returns use the Jun 5 open and the Jul 19 close. Not investment advice.